lymphadenopathy uniba 18-1-13
TRANSCRIPT
-
7/29/2019 Lymphadenopathy Uniba 18-1-13
1/34
Approach to
LymphadenopathyDr Putra Hendra SpPD
UNIBA
-
7/29/2019 Lymphadenopathy Uniba 18-1-13
2/34
Definition
Approx 600 LN in body
LAN = abnl size,
number, consistency
Generalized vs Local
Peripheral (central LAN
presents differently)
-
7/29/2019 Lymphadenopathy Uniba 18-1-13
3/34
Lymph Nodes
Anatomy
Collection of lymphoid cells attached to both vascular and
lymphatic systems
Over 600 lymph nodes in the body Function
To provide optimal sites for the concentration of free or cell-
associated antigens and recirculating lymphocytes
sensitization of the immune response To allow contact between B-cells, T-cells and macrophages
Lymphadenopathy - node greater than 1cm in size
-
7/29/2019 Lymphadenopathy Uniba 18-1-13
4/34
Why do lymph nodes enlarge?
Increase in the number of benign lymphocytesand macrophages in response to antigens
Infiltration of inflammatory cells in infection
(lymphadenitis) In situ proliferation of malignant lymphocytes or
macrophages
Infiltration by metastatic malignant cells Infiltration of lymph nodes by metabolite laden
macrophages (lipid storage diseases)
-
7/29/2019 Lymphadenopathy Uniba 18-1-13
5/34
Definitions
Pathologic Lymph Node
>2cm in children is considered abnormal
Acute Lymphadenopathy < 2 weeks duration
Subacute Lymphadenopathy
2-6 weeks duration Chronic Lymphadenopathy
> 6 weeks duration
-
7/29/2019 Lymphadenopathy Uniba 18-1-13
6/34
Epidemiology
0.6% annual incidence of unexplained
adenopathy in the general population
10% were referred to a subspecialist and 3.2 %
required a biopsy and 1.1% had a malignancy
-
7/29/2019 Lymphadenopathy Uniba 18-1-13
7/34
Epidemiology
Larsson et al. 38-45% of normal children have palpablecervical lymphadenopathy
Park et al. 90% of children aged 4-8 have lymphadenopathy
These masses can be mistaken for other local and systemicprocesses
Congenital Masses
Malignancies
Local presentation of systemic disease
Found by parents and caregivers and demand workup
-
7/29/2019 Lymphadenopathy Uniba 18-1-13
8/34
Physical Exam General
Febrile or toxic appearing
Skin
Cellulitis, impetigo, rash
HEENT
Otitis, pharyngitis, teeth, and nasal cavity
Neck Size
Unilateral vs Bilateral
Tender vs Nontender
Mobile vs Fixed
Hard vs Soft Lungs
Consolidations suggesting TB
Abdomen
Hepatosplenomegaly
Extremities Inguinal and Axillary adenopathy
-
7/29/2019 Lymphadenopathy Uniba 18-1-13
9/34
When to worry?
Age
Characteristics of the node
Location of the node Clinical setting associated with
lymphadenopathy
-
7/29/2019 Lymphadenopathy Uniba 18-1-13
10/34
Risk Factors to Keep in Mind Size Matters!!
In one series of 213 adults with unexplained LAN who
went on to biopsy
LN 1.5x1.5 (2.25 cm2) - 38% malignancy
Age Matters!! Age > 40, malignancy is more common
(Age >40 = 4% vs Age < 40 = 0.4%)
Location Matters!! Supraclavicular has the highest risk of Malignancy - est at
90% in patients >40 and 25% in ages < 40
-
7/29/2019 Lymphadenopathy Uniba 18-1-13
11/34
Characteristics of the node
ConsistencyHard/Firm vs Soft/Shotty; Fluctuant
Mobile vs Fixed/Matted
Tender vs Painless
Clearly demarcated
Size
When to worry1.5-2cm in size
Epitroclear nodes over 0.5cm; Inguinal over 1.5cm
Duration and Rate of Growth
-
7/29/2019 Lymphadenopathy Uniba 18-1-13
12/34
EXAMINATION OF A LUMP
Size
Consistency: Hodgkins rubbery
Tuberculosis matted
Metastatic cancer craggy
Calcified stony hard
Tenderness: infectious mononucleosis, dentalsepsis, tonsilitis
Fixation: malignancy
-
7/29/2019 Lymphadenopathy Uniba 18-1-13
13/34
Presentation of
lymphadenopathy
Unexplained
lymphadenopathy
3/4 presents with localized
1/4 present withgeneralized
-
7/29/2019 Lymphadenopathy Uniba 18-1-13
14/34
-
7/29/2019 Lymphadenopathy Uniba 18-1-13
15/34
-
7/29/2019 Lymphadenopathy Uniba 18-1-13
16/34
-
7/29/2019 Lymphadenopathy Uniba 18-1-13
17/34
Posterior Cervical LAN - Mono
-
7/29/2019 Lymphadenopathy Uniba 18-1-13
18/34
y -Scrofula
Lymphatic spread ofM. tuberculosisas wellas atypical mycobacteria (M. scrofulaceum,
MAI)
-
7/29/2019 Lymphadenopathy Uniba 18-1-13
19/34
Mycobacterial Lymphadenitis
-
7/29/2019 Lymphadenopathy Uniba 18-1-13
20/34
TB abscessas part of immune reconstitution syndrome
-
7/29/2019 Lymphadenopathy Uniba 18-1-13
21/34
Diagnostic Tests
Fine needle aspiration biopsy (FNAB)
Computed tomography (CT)
Magnetic resonance imaging (MRI) Ultrasonography
Radionucleotide scanning
-
7/29/2019 Lymphadenopathy Uniba 18-1-13
22/34
Role of Ultrasound (Ahuja et al.
2005) No radiation exposure
Good for following the progress of an abscess
Differentiate Reactive vs Malignant nodes Reactive
0.5cm)
No echogenic hilus Cogaulative necrosis present
High resistive index with low blood flow Extracapsular spread
Sensitivity 95% and Specificity 83% for differentiating reactive vs metastaticlymph nodes
-
7/29/2019 Lymphadenopathy Uniba 18-1-13
23/34
Fine Needle Aspiration Biopsy
Standard of diagnosis
IndicationsAny neck mass that is not an obvious abscess
Persistence after a 2 week course of antibiotics
Small gauge needle Reduces bleeding
Seeding of tumornot a concern No contraindications (vascular ?)
-
7/29/2019 Lymphadenopathy Uniba 18-1-13
24/34
Fine Needle Aspiration Biopsy
-
7/29/2019 Lymphadenopathy Uniba 18-1-13
25/34
Differential Diagnosis
r t n
-
7/29/2019 Lymphadenopathy Uniba 18-1-13
26/34
a or at ogensHIV- related persistent generalized
lymphadenopathy (PGL)
Opportunistic infections tuberculous lymphadenitis, CMV,toxoplasmosis, infections with Nocardiaspecies, fungal infections(histoplasmosis, penicilliosis,cryptococcus, etc.)
Reactive Lymphadenopathy pyomyositis, pyogenic skin infections,ear, nose, and throat (ENT) infections
STIs syphilis, inguinal lymphadenopathy dueto donovanosis, chancroid orlymphogranuloma venereum (LGV)(see WHO or MSF guidelines)
Malignancies lymphoma, Kaposis sarcoma
-
7/29/2019 Lymphadenopathy Uniba 18-1-13
27/34
Lymphadenitis
Very common, especially within 1st decade
Tender node with signs of systemic infection
Directed antibiotic therapy with follow-up FNAB indications (pediatric)
Actively infectious condition with no response
Progressively enlarging
Solitary and asymmetric nodal mass
Supraclavicular mass (60% malignancy)
Persistent nodal mass without active infection
-
7/29/2019 Lymphadenopathy Uniba 18-1-13
28/34
Generalized Lymphadenopathy
Malignancylymphoma, leukemia, Kaposis sarcoma,metastases
AutoimmuneSLE, RA, Sjogrens syndrome, Stills
disease, Dermatomyositis InfectiousBrucellosis, Cat-scratch disease, CMV,
HIV, EBV, Rubella, Tuberculosis, Tularemia, TyphoidFever, Syphilis, viral hepatitis, Pharyngitis
OtherKawasakis disease, sarcoidosis, amyloidosis,lipid storage diseases, hyperthyroidism, necrotizinglymphadenitis, histiocytosis X, Castlemens disease
-
7/29/2019 Lymphadenopathy Uniba 18-1-13
29/34
Granulomatous lymphadenitis
TypicalM. tuberculosis
more common in adults Posterior triangle nodes
Rarely seen in our population
Usually responds to anti-TB medications May require excisional biopsy for further workup
-
7/29/2019 Lymphadenopathy Uniba 18-1-13
30/34
Drug Induced Lymphadenopathy
Medications Phenytoin
Pyrimethamine
Allopurinol
Phenylbutazone
Isoniazide Immunizations
Smallpox (historically)
Live attenuated MMR
DPT
Poliomyelitis
Typhoid fever
**Usually self limited and resolves with cessation of medication orwith time in the case of immunization induced LAD
-
7/29/2019 Lymphadenopathy Uniba 18-1-13
31/34
Inguinal LAN
STDs
Tinea infections (pedis/cruris)
Pelvic/Genital Malignancy
(squamous/melanoma)
Bubonic Plague? - was there an exposure?
Lymphoma
-
7/29/2019 Lymphadenopathy Uniba 18-1-13
32/34
-
7/29/2019 Lymphadenopathy Uniba 18-1-13
33/34
Terima kasih
-
7/29/2019 Lymphadenopathy Uniba 18-1-13
34/34
Questions?